Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system

L Mazzolai1, J Nussberger, J F Aubert

  • 1Division of Hypertension and Vascular Medicine, University of Lausanne Medical School, Switzerland.

Insights

Local angiotensin II (Ang II) production in the heart drives cardiac hypertrophy, even without high blood pressure. This study shows Ang II acts as a growth factor, causing heart enlargement independently of hypertension.

Area of Science:

  • Cardiovascular Biology
  • Molecular Endocrinology
  • Renal Physiology

Background:

  • Cardiac hypertrophy is a common complication of chronic hypertension.
  • The renin-angiotensin system (RAS) effector, angiotensin II (Ang II), regulates blood pressure and hypertension.
  • Ang II is increasingly recognized for its role as a growth factor in the heart.

Purpose of the Study:

  • To investigate whether local Ang II production can induce cardiac hypertrophy independently of elevated blood pressure.
  • To elucidate the role of the cardiac RAS in mediating hypertrophic responses in vivo.

Main Methods:

  • Generation of transgenic mice with cardiac-specific overexpression of the rat angiotensinogen gene.
  • Assessment of cardiac morphology, including hypertrophy and fibrosis.
  • Monitoring of blood pressure to differentiate effects of Ang II from hypertension.

Main Results:

  • Transgenic mice developed significant myocardial hypertrophy.
  • Cardiac hypertrophy occurred without evidence of cardiac fibrosis.
  • The observed hypertrophy was independent of elevated blood pressure, indicating a direct trophic effect of local Ang II.

Conclusions:

  • Local production of Ang II in the heart is sufficient to induce cardiac hypertrophy.
  • Ang II acts as a direct growth factor in the myocardium, irrespective of systemic blood pressure.
  • Targeting local cardiac RAS may offer new therapeutic strategies for cardiac hypertrophy in non-hypertensive conditions.

Related Concept Videos

Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...